Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHOPHT.122.12.1844PMID 15596589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.

  2003influential reference
• Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease

  2003cited by this paper
• Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins

  2003cited by this paper
• The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.

  2003influential reference
• VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.

  2003cited by this paper
• VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization

  2003cited by this paper
• VEGF‐TRAPR1R2 suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrier

  2003cited by this paper
• uPAR: a versatile signalling orchestrator

  2002cited by this paper
• Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides

  2002cited by this paper
• An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.

  2002cited by this paper
• The role of the plasminogen activation system in angiogenesis and metastasis.

  2001cited by this paper
• Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis

  2001cited by this paper
• Extracellular Proteolysis and Angiogenesis

  2001cited by this paper
• Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.

  2000cited by this paper
• A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

  2000influential reference
• Quantitative image analysis of laser-induced choroidal neovascularization in rat.

  2000cited by this paper
• The plasminogen activation system in tumor growth, invasion, and metastasis

  2000cited by this paper
• Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.

  2000cited by this paper
• A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin.

  2000cited by this paper
• Retinal and choroidal neovascularization

  2000influential reference
• Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.

  1999cited by this paper
• Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.

  1999cited by this paper
• Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin One-Year Results of 2 Randomized Clinical Trials—TAP Report

  1999cited by this paper
• Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model.

  1998influential reference
• Essential role of growth hormone in ischemia-induced retinal neovascularization.

  1997cited by this paper
• Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.

  1996cited by this paper
• Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.

  1996cited by this paper
• Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

  1996cited by this paper
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

  1995cited by this paper
• Biology and biochemistry of proteinases in tumor invasion.

  1993cited by this paper
• Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

  1987cited by this paper

• Comparative Analysis of Molecular Landscape in Mouse Models and Patients Reveals Conserved Inflammation Pathways in Age-Related Macular Degeneration

  2024cites this paper
• Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues

  2022cites this paper
• Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium

  2021cites this paper
• The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy

  2021cites this paper
• Therapeutics targeting the fibrinolytic system

  2020cites this paper
• Pharmacokinetics of the Urokinase Receptor-Derived Peptide UPARANT After Single and Multiple Doses Administration in Rats

  2020cites this paper
• The uPAR System as a Potential Therapeutic Target in the Diseased Eye

  2019influential citation
• Drug delivery via porous silicon: a focused patent review.

  2017cites this paper
• The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.

  2016cites this paper
• Modulation of CD44 Activity by A6-Peptide

  2015cites this paper
• Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.

  2015cites this paper
• Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway

  2013cites this paper
• Novel Targets Against Retinal Angiogenesis in Diabetic Retinopathy

  2012cites this paper
• Intraocular Properties of a Repository Urokinase Receptor Antagonist Å36 Peptide in Rabbits

  2010cites this paper
• Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.

  2010cites this paper
• Vascular Basement Membrane Thickening in Diabetic Retinopathy

  2010cites this paper
• Extracellular Proteinases in Ocular Angiogenesis

  2008cites this paper
• Effect of Chrysin on Experimentally Induced Choroidal Neovascularization in Rats

  2008cites this paper
• Role of Urokinase Inhibitors in Choroidal Neovascularization

  2006cites this paper
• Emerging biological therapies for age-related macula degeneration

  2005cites this paper